Feb 8 - Gerald Commissiong @G_Commish "Last wee
Post# of 1418
(Total Views: 251)
Posted On: 02/10/2022 1:49:27 PM
Feb 8 - Gerald Commissiong @G_Commish
"Last week @todosmedical and I lost a close friend to COVID. We were unable to get Tollovir or any of our products to the patient due to hospital protocols. This is a deeply sad situation and one that underscores the mission we are on. Screening for COVID in patients sick with other respiratory infections is extremely important due the potential for late diagnosis of COVID infection. We understand the importance of getting Tollovir available in hospitals in the US and we are getting all the study reports completed so can soon submit IND to FDA. Too many patients are dying. #IHateCOVID"
This was Rich. Passed away Feb. 5th. 58 years young! Left behind a wife and two kids.
Can you imagine, you just saw the results of what Tollovir did and you can't get any due to hospital protocols? Sound like in addition to a respiratory infection, they realized later, he also had Covid, but too late.
Rich Galterio - Executive Vice President
Richard Galterio serves as Executive Vice President of Todos, bringing over 30 years of business development and capital markets experience. Prior to joining Todos, he served as Executive Vice President of BioHiTech Global where he helped guide the company through a series of transactions to o achieve a Nasdaq listing in 2018. During his four-year tenure at BioHiTech he helped orchestrate capital infusions of over $20 million and developed new business opportunities to leverage corporate assets and increase overall market capitalization.
In addition to having provided business development and marketing advisory services to numerous public and private companies, Mr. Galterio has over 16 years of experience in investment banking with a focus on early-stage companies. He has structured over $200 million in financings for developing companies and helped numerous companies achieve a national stock market listing. Mr. Galterio has a Bachelor of Science degree in Business Administration from Villanova University.
"Last week @todosmedical and I lost a close friend to COVID. We were unable to get Tollovir or any of our products to the patient due to hospital protocols. This is a deeply sad situation and one that underscores the mission we are on. Screening for COVID in patients sick with other respiratory infections is extremely important due the potential for late diagnosis of COVID infection. We understand the importance of getting Tollovir available in hospitals in the US and we are getting all the study reports completed so can soon submit IND to FDA. Too many patients are dying. #IHateCOVID"
This was Rich. Passed away Feb. 5th. 58 years young! Left behind a wife and two kids.
Can you imagine, you just saw the results of what Tollovir did and you can't get any due to hospital protocols? Sound like in addition to a respiratory infection, they realized later, he also had Covid, but too late.
Rich Galterio - Executive Vice President
Richard Galterio serves as Executive Vice President of Todos, bringing over 30 years of business development and capital markets experience. Prior to joining Todos, he served as Executive Vice President of BioHiTech Global where he helped guide the company through a series of transactions to o achieve a Nasdaq listing in 2018. During his four-year tenure at BioHiTech he helped orchestrate capital infusions of over $20 million and developed new business opportunities to leverage corporate assets and increase overall market capitalization.
In addition to having provided business development and marketing advisory services to numerous public and private companies, Mr. Galterio has over 16 years of experience in investment banking with a focus on early-stage companies. He has structured over $200 million in financings for developing companies and helped numerous companies achieve a national stock market listing. Mr. Galterio has a Bachelor of Science degree in Business Administration from Villanova University.
(1)
(0)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼